![A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine](https://www.thelancet.com/cms/asset/cf5e8046-e618-48ed-873e-1879d97e4e5c/gr1.jpg)
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine
![Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005 | The BMJ Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005 | The BMJ](https://www.bmj.com/sites/default/files/sites/defautl/files/attachments/bmj-article/2018/06/research_clinicaltrialsgov_drupal.jpg)
Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005 | The BMJ
![Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study - The Lancet Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study - The Lancet](https://www.thelancet.com/cms/attachment/e1b0b553-3259-494a-ae4a-3211d616472c/gr1.jpg)
Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study - The Lancet
![Recruitment of Black Adults into Cardiovascular Disease Trials | Journal of the American Heart Association Recruitment of Black Adults into Cardiovascular Disease Trials | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/13ef21df-50f4-4ed9-b7c8-0a8329ca19d2/jah36522-fig-0001.png)